The September 2008 edition of Positive Living, with in-depth coverage of the International AIDS Conference, dental health and bone disease in people with HIV.
AIDS 2008: Living with complexity
From the September 2008 issue of Positive Living
There will be no simple solution to the HIV/AIDS crisis, delegates to the 17th International AIDS Society World AIDS Conference have been told.
AIDS 2008: Criminalisation a hot topic
From the September 2008 issue of Positive Living
The criminalisation of HIV transmission or exposure was one of the burning issues at the World AIDS Conference and at a prior satellite meeting. South African Supreme Court Justice Edwin Cameron delivered a speech that called for an unambiguous rejection of the use of criminal law to regulate the sexual behaviour of those with or at risk of HIV.
AIDS 2008: The Swiss Statement – the debate continues
From the September 2008 issue of Positive Living
The President of the Swiss Federal AIDS Commission, which produced the controversial statement on the effect of treatment of HIV transmission earlier this year, made some qualifications to the statement on a panel of experts at the International AIDS Conference in Mexico City.
Victorian HIV transmission prosecutions
From the September 2008 issue of Positive Living
At the same time criminalisation issues were being discussed in Mexico City, two cases of HIV-transmission offences were being tried in Victoria.
US HIV travel ban to be lifted – but not yet
From the September 2008 issue of Positive Living
The long-standing ban on HIV-positive travellers entering the United States is expected to be lifted soon.
The bones of the matter
From the September 2008 issue of Positive Living
Studies have shown markedly higher rates of osteopenia and osteoporosis in people with HIV compared with the general population and the exact causes of this and the best treatments to be used have been the subject of some debate.
Liaisons with the dentist
From the September 2008 issue of Positive Living
If you are one of those people who hate the dentist then you just need to find one you really like. Adrian Ogier found a few he liked and discovered what good dental care is all about.
AIDS 2008: Is the HIV drug pipeline drying up?
From the September 2008 issue of Positive Living
The International AIDS Conference heard promising reports about the newer HIV treatments designed to help treat people with advanced and drug-resistant HIV, all of which are now available in Australia.
What's your problem?
From the September 2008 issue of Positive Living
Your chance to ask an HIV-experienced doctor about any medical query you might have. We are grateful to Dr Louise Owen, medical director of the Centre Clinic in St Kilda, who will be answering your questions.
Atazanavir switch doesn’t reduce belly fat
From the September 2008 issue of Positive Living
In a disappointing finding from the REAL study, little difference was shown in visceral fat levels from those who shifted to atazanavir/ritonavir versus those remaining on their existing boosted protease inhibitor.
Treating earlier: at 500 T-cells?
From the September 2008 issue of Positive Living
With increasing numbers of people with HIV developing non-AIDS illnesses, physicians are debating whether to start treatment earlier than is currently recommended.
Growth hormone reduces deep belly fat in HIV
From the September 2008 issue of Positive Living
A possible new treatment for excessive abdominal fat associated with HIV-related lipodystrophy was presented at IAS 2008.
Nanosuspension: a new treatment breakthrough?
From the September 2008 issue of Positive Living
A presentation at the International AIDS Conference looked at nanosuspension, a formulation of very small crystals which have been reduced to approximately twice the diameter of an HIV particle.
Circumcision will halve HIV rates over decades
From the September 2008 issue of Positive Living
Mathematical modelling suggests that HIV incidence could be halved if circumcision were adopted in developing countries, however the impact would not be fully felt for many decades.
New NNRTI shows early results
From the September 2008 issue of Positive Living
An experimental NNRTI, RDEA806, appeared to have strong antiviral activity and a favourable safety profile in a Phase II study presented at IAS 2008.
Rilpivirine (TMC-278)
From the September 2008 issue of Positive Living
Follow-up results from a Phase II study of rilpivirine (TMC-278), Tibotec’s experimental next generation NNRTI, indicate that when combined with Truvada or Combivir, rilpivirine has comparable results to the leading NNRTI, efavirenz.
A next generation NNRTI
From the September 2008 issue of Positive Living
New data about IDX899, an experimental next generation NNRTI, was presented at the International AIDS Conference, showing reduced viral load in test tube studies both in wild-type HIV and strains with NNRTI-resistance mutations.
PDF